The DUSP5 Knockout HeLa Polyclonal Cells are a genetically engineered cell pool derived from the HeLa human cervical adenocarcinoma line, featuring CRISPR/Cas9-mediated disruption of the dual-specificity phosphatase 5 (DUSP5) gene. This polyclonal knockout population provides a heterogeneous mixture of edited cells, enabling loss-of-function studies without single-cell clonal selection. By ablating DUSP5 expression, this product serves as a powerful tool for investigating negative feedback regulation within the MAPK/ERK cascade, a central signaling axis in cancer cell proliferation and survival.
The parental HeLa cell line, an HPV18-positive epithelial line isolated from a cervical adenocarcinoma, is one of the most widely utilized human cell models in biomedical research. Its robust growth characteristics, ease of genetic manipulation, and well-characterized oncogenic signaling networks make it an ideal host for targeted gene disruption. The cervical cancer origin of HeLa cells is particularly relevant for DUSP5, which has been implicated in the pathogenesis of cervical carcinoma and other malignancies, including colorectal, gastric, and melanoma cancers.
DUSP5 functions as a nuclear dual-specificity phosphatase that selectively dephosphorylates phosphothreonine and phosphotyrosine residues within the activation loop of extracellular signal-regulated kinases 1 and 2 (ERK1/2), thereby catalyzing their inactivation. This activity establishes a critical negative feedback loop within the MAPK/ERK pathway: activated ERK1/2, via ETS transcription factors, promotes DUSP5 transcription, which in turn dampens further ERK signaling. The pathway is initiated by upstream mitogenic stimuli such as epidermal growth factor (EGF) and fibroblast growth factor (FGF), leading to sequential activation of EGFR, RAS, RAF, and MEK1/2. In addition to ERK1/2, DUSP5 influences downstream effectors including the transcription factors ELK1, c-Fos, c-Myc, and cyclin D1. Nuclear import of DUSP5 is mediated by importin-??, and its activity may be modulated by scaffold proteins like KSR1.
Disruption of DUSP5 in HeLa cells is anticipated to prolong ERK1/2 phosphorylation, thereby enhancing transcriptional outputs that drive cell cycle progression and inhibit apoptosis. This polyclonal knockout model provides an experimentally tractable system for dissecting the tumor-suppressive or oncogenic roles of DUSP5 in cervical adenocarcinoma. Furthermore, the model facilitates exploration of DUSP5 involvement in other disease settings, such as cardiovascular disorders where MAPK/ERK fine-tuning is critical for cardiomyocyte hypertrophy and vascular remodeling.
Typical research applications include western blotting and RT-qPCR to quantify DUSP5 ablation and downstream ERK target gene expression; immunofluorescence to assess phospho-ERK localization; and functional assays such as MTT/BrdU proliferation, caspase-3/7 apoptosis, and Transwell migration/invasion to measure phenotypic changes. This polyclonal population is also suited for high-content screening of MAPK pathway modulators and phospho-kinase array profiling to uncover signaling cross-talk. RNA-sequencing enables transcriptome-wide analysis of DUSP5-dependent gene networks. For detailed protocols or custom inquiries, please contact Ascent Research.
